By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Fluvastatin

Fluvastatin

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|637 words

Fluvastatin Drug Profile

What is Fluvastatin?

Fluvastatin is a prescription medication that belongs to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels in the blood and reduce the risk of cardiovascular disease. Fluvastatin works by blocking an enzyme in the liver that produces cholesterol, helping to prevent heart attacks, strokes, and other complications related to high cholesterol.

Uses

Fluvastatin is prescribed for several cardiovascular conditions:

  • High cholesterol (hypercholesterolemia): Reduces elevated total cholesterol, LDL (“bad”) cholesterol, and triglycerides while modestly increasing HDL (“good”) cholesterol
  • Primary prevention of cardiovascular disease: Helps prevent first-time heart attacks and strokes in patients with risk factors such as diabetes, high blood pressure, or family history
  • Secondary prevention after cardiac events: Reduces the risk of future cardiovascular events in patients who have already experienced heart attacks or undergone cardiac procedures
  • Mixed dyslipidemia: Treats multiple lipid abnormalities including elevated cholesterol and triglycerides
  • Prevention of coronary artery disease progression: Slows the buildup of plaque in coronary arteries

How it works

Fluvastatin works by inhibiting HMG-CoA reductase, a key enzyme that controls cholesterol production in the liver. By blocking this enzyme, the medication reduces the amount of cholesterol the body makes naturally, forcing the liver to remove more cholesterol from the blood. This dual action significantly lowers blood cholesterol levels and helps prevent the formation of arterial plaque that can lead to heart disease and stroke.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle aches or weakness
  • Nausea and stomach upset
  • Diarrhea or constipation
  • Dizziness
  • Joint pain
  • Upper respiratory infections
  • Fatigue

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, weakness, or breakdown (rhabdomyolysis)
  • Signs of liver problems (yellowing of skin or eyes, dark urine, persistent nausea)
  • Unexplained muscle tenderness with fever or malaise
  • Memory problems or confusion
  • Kidney problems with decreased urination

Warnings and precautions

  • Liver disease: Patients with active liver disease or unexplained elevated liver enzymes should not take fluvastatin. Regular liver function monitoring may be required.
  • Pregnancy and breastfeeding: Fluvastatin is contraindicated during pregnancy and breastfeeding as it may harm fetal development and can pass into breast milk.
  • Muscle disorders: Patients with a history of muscle disorders or those taking multiple medications that affect muscles should be closely monitored for signs of muscle toxicity.
  • Kidney impairment: Dose adjustments may be necessary in patients with severe kidney disease.
  • Age considerations: Elderly patients may be more susceptible to muscle-related side effects and may require lower doses or closer monitoring.

Interactions

Fluvastatin can interact with several medications and supplements:

  • Warfarin: May increase bleeding risk by enhancing warfarin’s anticoagulant effects
  • Gemfibrozil and other fibrates: Significantly increases risk of muscle toxicity and should generally be avoided
  • Cyclosporine: Increases fluvastatin levels, requiring dose reduction and careful monitoring
  • Rifampin: Reduces fluvastatin effectiveness by increasing its metabolism
  • Phenytoin: May increase phenytoin levels, requiring monitoring for toxicity
  • Glyburide: Can enhance blood sugar-lowering effects
  • Colestipol and cholestyramine: May reduce fluvastatin absorption when taken together
  • Grapefruit juice: Large amounts may increase drug levels, though the effect is less pronounced than with other statins

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages for fluvastatin range from 20 mg to 80 mg daily, taken orally. The immediate-release formulation is usually taken twice daily with the evening dose being larger, while extended-release tablets are taken once daily in the evening. Starting doses typically range from 20-40 mg daily, with adjustments made every 4-6 weeks based on cholesterol response and tolerance. Maximum daily dose is 80 mg. Dosage should always be individualized and determined by a healthcare provider based on the patient’s cholesterol levels, cardiovascular risk factors, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Fluvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/fluvastatin-5/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Why Women Choose Freebirth: What Research Reveals About Unattended Childbirth

A growing number of women are choosing unattended childbirth, driven by desire…

The Optimal Height for Elite Soccer Players: What Sports Science Reveals

Elite soccer demonstrates position-specific height selection rather than universal stature advantage. Analysis…

International Survey Reveals Critical Gaps in Cardio-Oncology Training Despite Rising Clinical Demand

An international survey presented at ESC Cardio-Oncology 2026 has identified substantial deficiencies…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Pitavastatin

By
Prof. Giorgi Pkhakadze
01/06/2026

Rosuvastatin

By
Prof. Giorgi Pkhakadze
01/06/2026

Atorvastatin

By
Prof. Giorgi Pkhakadze
01/06/2026

Pitavastatin

By
Prof. Giorgi Pkhakadze
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up